Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Karen Long


Ms. Karen Long serves as Chief Executive Officer and President at Nuelle. She is one of the early founding members of the Nuelle team. She has focused her career in health and wellness first starting in direct patient care and then moving to medical technology. She was World Wide Vice President of Marketing for Acclarent, a novel Ear, Nose and Throat company focused on the unmet needs of people who suffer from chronic sinusitis. Acclarent was founded in 2005 and acquired by Johnson & Johnson in 2010. Prior to Acclarent, Karen held various management positions in marketing and product development at consumer diagnostics companies: Lifescan, a Johnson & Johnson company, Inverness Medical, and Chemtrak. Karen loves to help new brands get to market and has been an essential early stage team member at many successful start-ups most recently Coravin, a breakthrough wine access technology co-founded by Dr. Joshua Makower, Founder of Nuelle. Karen holds graduate and postgraduate degrees in Social Work from San Diego State University.

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Primary Office
  • San Francisco, CA
  • United States

Karen Long Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Lully 01-Jun-2015 Seed Round 00.00 Electronics (B2C) Startup 00000 0000
0000000 11-Apr-2011 00000 00000 00000 Beverages Generating Revenue 00000 0000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Karen Long’s full profile, request a free trial.

Karen Long Team (1)

Name Title Deals Funds Boards Office Contact
Karen Long Angel Investor 0 San Francisco, CA

Karen Long Co-Investors (13)

Name With Exits Lead Partner
8capita 1 0
StartX 0 0
VentureWell 0 0
WS Investments 0 0
Y Combinator 0 0
To view this investor’s complete co-investor history, request access »